See ratings and reviews when you sign up for an account.

Doctoral CRP on Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients

This study is currently Recruiting

October 2011 By International Atomic Energy Agency

First Recieved on July 19, 2005

Last Updated on October 12, 2011

Sponsor: International Atomic Energy Agency
Information provided by: International Atomic Energy Agency
Identifier: NCT00122746


The researchers plan: - To undertake clinical studies of radiotherapy with or without the administration of the chemotherapeutic agent cisplatin, known to be a radiosensitizer; - To perform pre-clinical studies of the radiosensitivity of human fibroblasts and cervical cancer cell lines in culture, with or without the addition of various HIV proteins or protease inhibitors, in order to determine the extent of any cellular radiosensitizing properties of these molecules; - To develop strategies for sensitizing tumour cells to radiation, specifically by down-regulating specific viral proteins that are known to be factors associated with resistance to radiotherapy.

Study Type: Interventional
Study Design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Ages Eligible for Study:18 Years
Genders Eligible for Study:Female
Accepts Healthy Volunteers:No

Inclusion Criteria: - Cancer of the cervix - AIDS Exclusion Criteria: - Unable to give informed consent


  • Investigator: Eduardo H. Zubizarreta, M.D. - Study Director - International Atomic Energy Agency


  • Dept. of Atomic Energy, Tata Memorial Centre

    Mumbai, India

  • Johannesburg Hospital

    Johannesburg, South Africa

  • Ocean Road Cancer Institute

    Dar Es Salaam, Tanzania

  • Radiotherapy Centre

    Kampala, Uganda

  • Radiotherapy Centre

    Harare, Zimbabwe

Disclaimer: The list and ratings above are for informational purposes only, and is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. The goal of the information is to provide you with a comprehensive view of all available treatments, but should not be construed to indicate that use of any one treatment is safe, appropriate, or effective for you. Decisions about use of a new treatment, or about a change in your current treatment plan, should be in consultation with your doctor or other healthcare professional.